Aemetis, Inc. (NASDAQ:AMTX) Short Interest Update

Aemetis, Inc. (NASDAQ:AMTX) saw a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 5,320,000 shares, a growth of 14.7% from the March 15th total of 4,640,000 shares. Based on an average daily trading volume, of 1,220,000 shares, the days-to-cover ratio is presently 4.4 days.

Institutional Trading of Aemetis

Hedge funds have recently made changes to their positions in the business. Stifel Financial Corp raised its holdings in Aemetis by 58.0% in the third quarter. Stifel Financial Corp now owns 691,445 shares of the specialty chemicals company’s stock valued at $2,870,000 after acquiring an additional 253,745 shares in the last quarter. State Street Corp raised its holdings in Aemetis by 9.6% in the first quarter. State Street Corp now owns 1,998,092 shares of the specialty chemicals company’s stock valued at $25,316,000 after acquiring an additional 175,009 shares in the last quarter. Marshall Wace LLP acquired a new stake in Aemetis in the third quarter valued at approximately $1,008,000. Millennium Management LLC raised its holdings in Aemetis by 14.5% in the fourth quarter. Millennium Management LLC now owns 1,007,208 shares of the specialty chemicals company’s stock valued at $3,989,000 after acquiring an additional 127,674 shares in the last quarter. Finally, ExodusPoint Capital Management LP raised its holdings in Aemetis by 223.1% in the fourth quarter. ExodusPoint Capital Management LP now owns 180,050 shares of the specialty chemicals company’s stock valued at $713,000 after acquiring an additional 124,319 shares in the last quarter. Institutional investors and hedge funds own 27.02% of the company’s stock.

Analyst Ratings Changes

A number of research firms have commented on AMTX. Stifel Nicolaus decreased their target price on shares of Aemetis from $8.00 to $6.50 and set a “buy” rating on the stock in a research report on Wednesday, February 21st. Truist Financial decreased their target price on shares of Aemetis from $5.00 to $3.50 and set a “hold” rating on the stock in a research report on Tuesday, January 23rd.

Aemetis Stock Performance

Shares of AMTX traded down $0.21 during mid-day trading on Monday, hitting $4.08. 608,112 shares of the company’s stock were exchanged, compared to its average volume of 1,168,221. The company has a market cap of $173.84 million, a price-to-earnings ratio of -3.09 and a beta of 1.01. Aemetis has a fifty-two week low of $1.16 and a fifty-two week high of $8.99. The stock’s 50-day moving average is $4.08 and its 200-day moving average is $4.34.

Aemetis (NASDAQ:AMTX) last issued its quarterly earnings results on Thursday, March 7th. The specialty chemicals company reported ($0.34) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.35) by $0.01. The business had revenue of $70.76 million for the quarter, compared to analyst estimates of $80.08 million. During the same period in the prior year, the company posted ($0.63) EPS. As a group, equities research analysts anticipate that Aemetis will post -1.44 EPS for the current year.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.